Your browser doesn't support javascript.
loading
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs.
Buffart, Laurien M; Kalter, Joeri; Sweegers, Maike G; Courneya, Kerry S; Newton, Robert U; Aaronson, Neil K; Jacobsen, Paul B; May, Anne M; Galvão, Daniel A; Chinapaw, Mai J; Steindorf, Karen; Irwin, Melinda L; Stuiver, Martijn M; Hayes, Sandi; Griffith, Kathleen A; Lucia, Alejandro; Mesters, Ilse; van Weert, Ellen; Knoop, Hans; Goedendorp, Martine M; Mutrie, Nanette; Daley, Amanda J; McConnachie, Alex; Bohus, Martin; Thorsen, Lene; Schulz, Karl-Heinz; Short, Camille E; James, Erica L; Plotnikoff, Ron C; Arbane, Gill; Schmidt, Martina E; Potthoff, Karin; van Beurden, Marc; Oldenburg, Hester S; Sonke, Gabe S; van Harten, Wim H; Garrod, Rachel; Schmitz, Kathryn H; Winters-Stone, Kerri M; Velthuis, Miranda J; Taaffe, Dennis R; van Mechelen, Willem; Kersten, Marie-José; Nollet, Frans; Wenzel, Jennifer; Wiskemann, Joachim; Verdonck-de Leeuw, Irma M; Brug, Johannes.
Afiliação
  • Buffart LM; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: l.buffart@vumc.nl.
  • Kalter J; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: j.kalter@vumc.nl.
  • Sweegers MG; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: m.sweegers@vumc.nl.
  • Courneya KS; Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Canada. Electronic address: kerry.courneya@ualberta.ca.
  • Newton RU; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia. Electronic address: r.newton@ecu.edu.au.
  • Aaronson NK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: n.aaronson@nki.nl.
  • Jacobsen PB; Division of Population Science, Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: Paul.Jacobsen@moffitt.org.
  • May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: a.m.may@umcutrecht.nl.
  • Galvão DA; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia. Electronic address: d.galvao@ecu.edu.au.
  • Chinapaw MJ; Department of Public and Occupational Health, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: m.chinapaw@vumc.nl.
  • Steindorf K; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Disease (NCT), Heidelberg, Germany. Electronic address: k.steindorf@dkfz-heidelberg.de.
  • Irwin ML; Yale School of Public Health, New Haven, USA. Electronic address: melinda.irwin@yale.edu.
  • Stuiver MM; Department of Physiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: m.stuiver@nki.nl.
  • Hayes S; School of Public Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, Australia. Electronic address: sc.hayes@qut.edu.au.
  • Griffith KA; School of Nursing, University of Maryland, Baltimore, USA. Electronic address: Griffith@son.umaryland.edu.
  • Lucia A; European University, Madrid, Spain. Electronic address: alejandro.lucia@uem.es.
  • Mesters I; Department of Epidemiology, Maastricht University, The Netherlands. Electronic address: ilse.mesters@maastrichtuniversity.nl.
  • van Weert E; University Medical Centre Groningen, University of Groningen, Center for Rehabilitation, Groningen, The Netherlands. Electronic address: e.van.weert@rev.umcg.nl.
  • Knoop H; Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: hans.knoop@amc.uva.nl.
  • Goedendorp MM; Department of Health Psychology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: m.m.goedendorp@med.umcg.nl.
  • Mutrie N; Physical Activity for Health Research Center, University of Edinburgh, Edinburgh, UK. Electronic address: nanette.mutrie@ed.ac.uk.
  • Daley AJ; Primary Care Clinical Sciences, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Electronic address: a.daley@bham.ac.uk.
  • McConnachie A; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK. Electronic address: alex.mcconnachie@glasgow.ac.uk.
  • Bohus M; Institute of Psychiatric and Psychosomatic Psychotherapy, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany; Faculty of Health, University of Antwerp, Belgium. Electronic address: martin.bohus@zi-mannheim.de.
  • Thorsen L; National Advisory Unit on Late Effects after Cancer, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: LKA@ous-hf.no.
  • Schulz KH; Athleticum - Competence Center for Sports- and Exercise Medicine and Institute for Medical Psychology, University Medical Center Hamburg-Eppendorf, Germany. Electronic address: khschulz@uke.uni-hamburg.de.
  • Short CE; Freemasons Foundation Centre of Men's Health, School of Medicine, University of Adelaide, SA, Australia. Electronic address: camille.short@adelaide.edu.au.
  • James EL; School of Medicine & Public Health, the University of Newcastle, Callaghan, NSW, Australia. Electronic address: erica.james@newcastle.edu.au.
  • Plotnikoff RC; Priority Research Centre for Physical Activity and Nutrition, the University of Newcastle, Callaghan, NSW, Australia. Electronic address: ron.plotnikoff@newcastle.edu.au.
  • Arbane G; Lane Fox Respiratory Research Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: Gill.Arbane@gstt.nhs.uk.
  • Schmidt ME; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Disease (NCT), Heidelberg, Germany. Electronic address: m.schmidt@dkfz.de.
  • Potthoff K; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany; Department of Radiation Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany. Electronic address: karin_potthoff@gmx
  • van Beurden M; Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: m.v.beurden@nki.nlm.
  • Oldenburg HS; Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: h.oldenburg@nki.nl.
  • Sonke GS; Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: g.sonke@nki.nl.
  • van Harten WH; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; University of Twente, Enschede, The Netherlands. Electronic address: w.v.harten@nki.nl.
  • Garrod R; Department of Respiratory Medicine, Kings College London, London, UK. Electronic address: rachelgarrod1@gmail.com.
  • Schmitz KH; Penn State Health, College of Medicine, and Cancer Institute, Hershey, PA, USA. Electronic address: kschmitz@phs.psu.edu.
  • Winters-Stone KM; Oregon Health & Science University, Portland, USA. Electronic address: wintersk@ohsu.edu.
  • Velthuis MJ; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. Electronic address: M.Velthuis@iknl.nl.
  • Taaffe DR; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia. Electronic address: d.taaffe@ecu.edu.au.
  • van Mechelen W; Department of Public and Occupational Health, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: w.vanmechelen@vumc.nl.
  • Kersten MJ; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: m.j.kersten@amc.uva.nl.
  • Nollet F; Department of Rehabilitation Medicine, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: f.nollet@amc.uva.nl.
  • Wenzel J; Johns Hopkins School of Nursing, Johns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA. Electronic address: jwenzel@jhu.edu.
  • Wiskemann J; Lane Fox Respiratory Research Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: joachim.wiskemann@nct-heidelberg.de.
  • Verdonck-de Leeuw IM; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands; Department of Clinical Psychology, Vrije Universiteit Amsterdam, The Netherlands. Electronic address: im.verdonck@vumc.nl.
  • Brug J; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Amsterdam School of Communication Research (ASCoR), University of Amsterdam, Amsterdam, The Netherlands. Electronic address: j.brug@uva.nl.
Cancer Treat Rev ; 52: 91-104, 2017 Jan.
Article em En | MEDLINE | ID: mdl-28006694
ABSTRACT
This individual patient data meta-analysis aimed to evaluate the effects of exercise on quality of life (QoL) and physical function (PF) in patients with cancer, and to identify moderator effects of demographic (age, sex, marital status, education), clinical (body mass index, cancer type, presence of metastasis), intervention-related (intervention timing, delivery mode and duration, and type of control group), and exercise-related (exercise frequency, intensity, type, time) characteristics. Relevant published and unpublished studies were identified in September 2012 via PubMed, EMBASE, PsycINFO, and CINAHL, reference checking and personal communications. Principle investigators of all 69 eligible trials were requested to share IPD from their study. IPD from 34 randomised controlled trials (n=4519 patients) that evaluated the effects of exercise compared to a usual care, wait-list or attention control group on QoL and PF in adult patients with cancer were retrieved and pooled. Linear mixed-effect models were used to evaluate the effects of the exercise on post-intervention outcome values (z-score) adjusting for baseline values. Moderator effects were studies by testing interactions. Exercise significantly improved QoL (ß=0.15, 95%CI=0.10;0.20) and PF (ß=0.18, 95%CI=0.13;0.23). The effects were not moderated by demographic, clinical or exercise characteristics. Effects on QoL (ßdifference_in_effect=0.13, 95%CI=0.03;0.22) and PF (ßdifference_in_effect=0.10, 95%CI=0.01;0.20) were significantly larger for supervised than unsupervised interventions. In conclusion, exercise, and particularly supervised exercise, effectively improves QoL and PF in patients with cancer with different demographic and clinical characteristics during and following treatment. Although effect sizes are small, there is consistent empirical evidence to support implementation of exercise as part of cancer care.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exercício Físico / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exercício Físico / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article